The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs & Medical Devices ReNu MoistureLoc Research Center

FDA ReNu Recall

in this section: FDA ReNu Recall | W & L Press Release | FDA: Failure to Report, 11.06 | B&L Responds: ReNu FDA Letter 11.06 | FDA Warning | Litigation Proliferates, 10.07 | FDA Supports Withdrawal | FDA Public Health Notice | B&L Sales Fall | Bausch & Lomb Press Release | MultiPlus Recall, 3/07 | ReNu lawsuit


Bookmark This Page Print This Page Email This Page

Recall of 1.5 Million Bottles of ReNu MultiPlus


BREAKING NEWS: AMO Complete MoisturePlus Multi-Purpose Solution has been recalled by its manufacturer due to an infection that may lead to blindness. To learn more about the recall and the dangers associated with it, click HERE.


BREAKING NEWS
Recall of 1.5 Million Bottles of ReNu MultiPlus
March 7, 2007, New York, NY—After receiving reports from customers complaining of discolored ReNu MultiPlus contact lens solution, Bausch & Lomb Inc. is pulling about 1.5 million bottles off store shelves, reports the Associated Press. The company says the discoloration is caused by trace amounts of iron found in a batch of raw material from an outside supplier.

The recalled lots for the current ReNu MultiPlus recall all carry the expiration date “2008 – 03” on the bottle. The lot numbers for the recall include: GC6030, GC6037, GC6038, GC6045, GC6048, GC6052, GC6061, GC6063, GC6072, GC6073, GC6080 and GC6085.

New Development in Canada: If you are in Canada, and you believe you have been injured by tainted batches of Bausch & Lomb's ReNu products click here for a free case evaluation.


FDA Announces the Recall of Bausch & Lomb's Renu with MoistureLoc Solution from Shelves Worldwide

A Warning to All ReNu users: Your Eyes May be in Danger!

It has come to light that ReNu with MoistureLoc may trigger a variety of harmful side effects, including some extremely dangerous ones like the fusarium keratitis fungus, blindness or corneal ulcers. It has been recalled from pharmacy and supermarket shelves.

To learn more about the origin of the recall from the FDA, read below.

If you or someone you love has suffered after using ReNu MoistureLoc, you may be entitled to a lawsuit. All you need to do is fill out a form and you will receive a free case evaluation from Weitz & Luxenberg.


FDA Statement
FOR IMMEDIATE RELEASE
Statement
May 15, 2006
Media Inquiries:
Kristen Neese, 301-827-6242
Consumer Inquiries:
888-INFO-FDA

Bausch & Lomb Global Recall of ReNu with MoistureLoc Contact Lens Cleaning Solution On Thursday, May 11, 2006 a team from Bausch & Lomb met with Food & Drug Administration (FDA) officials to share information resulting from the company's internal investigation into cases of Fusarium keratitis associated with ReNu with MoistureLoc.

Bausch & Lomb has proposed that unique characteristics of the formulation of the ReNu with MoistureLoc product in certain unusual circumstances can increase the risk of Fusarium infection.

Based on this scientific and epidemiological data suggesting that ReNu with MoistureLoc may increase susceptibility to Fusarium , Bausch & Lomb has decided to permanently remove the ReNu with MoistureLoc product worldwide. FDA supports this decision. To date, data available do not indicate a problem with ReNu MultiPlus or ReNu Multi-Purpose or generic brands of this contact lens cleaning solution.

While FDA is still concluding its scientific evaluations and expects additional information to be submitted by the sponsor, at this time we recognize that Bausch & Lomb has proposed the formulation as the potential root cause of the increased relative risk of Fusarium keratitis associated with use of the ReNu with MoistureLoc product. FDA will continue to review cultures and epidemiological data and if there is new information that adds to or changes our current understanding, we will act on it in a timely and appropriate manner.

As part of the joint Center for Disease Control & Prevention (CDC) and FDA investigation, field officers have been inspecting the Bausch & Lomb plant and facilities in Greenville , SC since March 22, 2006 . While the plant inspection is being finalized, there is still some additional testing to be completed. The agency plans to issue observations from the inspections imminently.

ReNu with MoistureLoc contact lens solution, manufactured in the Greenville , SC plant, was voluntarily withdrawn from the market in the United States on April 13, 2006 . To date, a majority of the confirmed Fusarium cases have been associated with the ReNu with MoistureLoc. Our interest in the MoistureLoc product has been based on the disproportionate number of cases of Fusarium keratitis associated with ReNu with Moisture Loc compared to the overall product market share. Based on CDC reports, the number of cases involving various contact lens solutions other than MoistureLoc has remained consistent throughout our investigation, and not disproportionate from the routine incidence of this infection in the population.

####


see also:

B&L Sales Fall Recall of Renu With MoistureLoc Results in Falling Sales for B&L
Lower 2006 Sales Due to Worldwide Recall of Renu MoistureLoc

FDA Warning FDA warns against Bausch & Lomb's ReNu with MoistureLoc lens solution
Legal help for people with eye infections from Bausch & Lomb's ReNu

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims